EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case report: Metreleptin rapidly improved anorexia nervosa related and comorbid psychopathology in a patient with high endogenous leptin levels adjusted for body mass index

Jochen Antel, Gertraud Gradl-Dietsch, Triinu Peters, Lutz Pridzun, Franziska Degenhardt, Linda von Piechowski, Anke Hinney, Johannes Hebebrand

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-025-02809-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Jochen Antel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, LVR-University Hospital Essen, University of Duisburg-Essen, Wickenburgstrasse 21, 45147, Essen, Germa…. Hauptthemen laut MEDLINE: Leptin, Anorexia Nervosa, Major Depressive Disorder, Obsessive-Compulsive Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Off-label treatment of a 17-year-old female patient with anorexia nervosa (AN), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), and non-suicidal self-injury (NSSI) with human recombinant leptin (metreleptin) for two dosing periods of 15 and seven days was associated with self- and clinician-rated improvements of eating disorder related psychopathology, OCD, depression, and NSSI. These intermittent improvements occurred despite the patient having high endogenous serum leptin levels ranging up to the 99th centile adjusted for sex, Tanner stage and body mass index (BMI; kg/m²) upon initiation of dosing. The results further extend the hypothesized effects of metreleptin on AN and comorbid psychopathology to patients with adjusted leptin levels in the normal to high range. We hypothesize that for unknown reasons the clinical symptomatology of a subgroup of patients with AN persists despite attainment of endogenous leptin levels well above those characteristic of the state of starvation, potentially entailing a prolonged entrapment in the eating disorder. An insight into the mechanisms underlying this distinct type of leptin resistance may help to promote recovery of such affected patients. Placebo controlled randomized clinical trials are required to assess if and to what extent short and medium term metreleptin treatment indeed improves recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinAnorexia NervosaMajor Depressive DisorderObsessive-Compulsive DisorderStress Disorders, Post-TraumaticSelf-Injurious BehaviorHumansFemaleAdolescentBody Mass IndexComorbidityTreatment Outcome

Stichwörter der Autor:innen

Anorexia nervosaAntidepressantHyperleptinemiaHypoleptinemiaLeptinStarvation

Substanzen

Leptinmetreleptin

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, LVR-University Hospital Essen, University of Duisburg-Essen, Wickenburgstrasse 21, 45147, Essen, Germany. jochen.antel@uni-due.de.
  • Center for Translational Neuro- and Behavioural Sciences, University Hospital Essen, Essen, Germany. jochen.antel@uni-due.de.
  • Department of Child and Adolescent Psychiatry, LVR-University Hospital Essen, University of Duisburg-Essen, Wickenburgstrasse 21, 45147, Essen, Germany.
  • Section for Molecular Genetics of Mental Disorders, University Hospital Essen, Essen, Germany.
  • Center for Translational Neuro- and Behavioural Sciences, University Hospital Essen, Essen, Germany.
  • Institute of Sex- and Gender-Sensitive Medicine, University Hospital Essen, Essen, Germany.

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Antel, J., Gradl-Dietsch, G., Peters, T., Pridzun, L., Degenhardt, F., von Piechowski, L., Hinney, A., & Hebebrand, J. (2025). Case report: Metreleptin rapidly improved anorexia nervosa related and comorbid psychopathology in a patient with high endogenous leptin levels adjusted for body mass index. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-025-02809-3

Vancouver

Antel J, Gradl-Dietsch G, Peters T, Pridzun L, Degenhardt F, von Piechowski L, et al. Case report: Metreleptin rapidly improved anorexia nervosa related and comorbid psychopathology in a patient with high endogenous leptin levels adjusted for body mass index. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-025-02809-3

BibTeX
@article{Antel2025,
  author = {Antel, Jochen and Gradl-Dietsch, Gertraud and Peters, Triinu and Pridzun, Lutz and Degenhardt, Franziska and von Piechowski, Linda and Hinney, Anke and Hebebrand, Johannes},
  title = {Case report: Metreleptin rapidly improved anorexia nervosa related and comorbid psychopathology in a patient with high endogenous leptin levels adjusted for body mass index},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-025-02809-3}
}
Kostenlos starten →